Russell Hayward

Executive Officer, Director at Etira.

Raised on Etira filings

$2.3M

of $3M offered across 1 Form D filing

Form D filings: 1
Teammates: 4
Last filing: May 14, 2026

Company

Biotech · Dallas, TX

Oral small-molecule drugs for therapy-resistant cancers

Oral small-molecule drugs for therapy-resistant cancers

Investors: 21
Still open: $722K

Investors: 21
Sector: Biotech
HQ: Dallas, TX

Etira filings

Etira Form D filings
Filed	Security	Sold of offered	Filing
May 14, 2026	Equity	$2.3M/ $3M	Form D

EquityFiled May 14, 2026Form D
$2.3M/ $3M

Works with

Also named on Etira filings

Russel HaywardChief Executive Officer, Form D signerForm D signer Annalisa JenkinsDirector Ganesh RajExecutive Officer, Director Justin StebbingDirector